These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29160660)

  • 1. Sugammadex: hunting for new side effects?
    Bertini P; Guarracino F
    Minerva Anestesiol; 2018 Feb; 84(2):150-151. PubMed ID: 29160660
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose of sugammadex in morbidly obese patients.
    Carron M; Zarantonello F; Ori C
    Anaesthesia; 2016 Jun; 71(6):730-1. PubMed ID: 27159001
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrected versus total body weight for dosage of sugammadex in morbidly obese patients. A randomized, double-blind, controlled trial.
    Carron M; Ieppariello G; DE Cassai A; Lambertini C; Linassi F; Navalesi P
    Minerva Anestesiol; 2021 Mar; 87(3):371-373. PubMed ID: 33325220
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose of sugammadex in morbidly obese patients - a reply.
    Loupec T; Frasca D; Debaene B
    Anaesthesia; 2016 Jun; 71(6):731-2. PubMed ID: 27159002
    [No Abstract]   [Full Text] [Related]  

  • 5. Sugammadex for treatment of postoperative residual curarization in a morbidly obese patient.
    Carron M; Freo U; Ori C
    Can J Anaesth; 2012 Aug; 59(8):813-4. PubMed ID: 22585470
    [No Abstract]   [Full Text] [Related]  

  • 6. Does reversal of neuromuscular block with sugammadex reduce readmission rate after surgery?
    Bose S; Xu X; Eikermann M
    Br J Anaesth; 2019 Mar; 122(3):294-298. PubMed ID: 30770044
    [No Abstract]   [Full Text] [Related]  

  • 7. Is appropriately conducted neostigmine reversal inferior to sugammadex?
    Zealley K; Taylor A; Raju P; Rodney G
    Anaesthesia; 2018 Sep; 73(9):1166-1167. PubMed ID: 30132814
    [No Abstract]   [Full Text] [Related]  

  • 8. The 'cost' of sugammadex.
    Maddock A
    Anaesthesia; 2017 Dec; 72(12):1558-1559. PubMed ID: 29130284
    [No Abstract]   [Full Text] [Related]  

  • 9. Sugammadex in rocuronium anaphylaxis: dose matters.
    Barthel F; Stojeba N; Lyons G; Biermann C; Diemunsch P
    Br J Anaesth; 2012 Oct; 109(4):646-7. PubMed ID: 22976863
    [No Abstract]   [Full Text] [Related]  

  • 10. Sugammadex after magnesium sulphate administration in a morbidly obese patient undergoing general anaesthesia.
    Carron M
    Br J Anaesth; 2014 May; 112(5):949-50. PubMed ID: 24771796
    [No Abstract]   [Full Text] [Related]  

  • 11. Sugammadex: a revolutionary approach to neuromuscular antagonism.
    Kopman AF
    Anesthesiology; 2006 Apr; 104(4):631-3. PubMed ID: 16571954
    [No Abstract]   [Full Text] [Related]  

  • 12. Benefit of sugammadex on lung ventilation evaluated with electrical impedance tomography in a morbidly obese patient undergoing bariatric surgery.
    Carron M; Galzignato C; Godi I; Ori C
    J Clin Anesth; 2016 Jun; 31():78-9. PubMed ID: 27185682
    [No Abstract]   [Full Text] [Related]  

  • 13. Appropriate dosing of sugammadex to reverse deep rocuronium-induced neuromuscular blockade in morbidly obese patients.
    Loupec T; Frasca D; Rousseau N; Faure JP; Mimoz O; Debaene B
    Anaesthesia; 2016 Mar; 71(3):265-72. PubMed ID: 26685122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness versus Efficacy of Calabadion and Sugammadex for Nondepolarizing Neuromuscular Blocking Agent Reversal.
    Lim G; Landsittel DP
    Anesthesiology; 2016 Jun; 124(6):1417. PubMed ID: 27187129
    [No Abstract]   [Full Text] [Related]  

  • 15. Antagonism of moderate neuromuscular block with sugammadex versus neostigmine.
    Muggleton E; Muggleton T
    Br J Anaesth; 2017 Mar; 118(3):459-460. PubMed ID: 28203767
    [No Abstract]   [Full Text] [Related]  

  • 16. Sugammadex: a novel approach to reversal of neuromuscular blockade.
    Aniskevich S; Leone BJ; Brull SJ
    Expert Rev Neurother; 2011 Feb; 11(2):185-98. PubMed ID: 21306205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sugammadex: a selective relaxant binding agent for reversal of neuromuscular block.
    Hogg RM; Mirakhur RK
    Expert Rev Neurother; 2009 May; 9(5):599-608. PubMed ID: 19402771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Myth of Rescue Reversal in "Can't Intubate, Can't Ventilate" Scenarios.
    Naguib M; Brewer L; LaPierre C; Kopman AF; Johnson KB
    Anesth Analg; 2016 Jul; 123(1):82-92. PubMed ID: 27140684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sugammadex: A Review of Neuromuscular Blockade Reversal.
    Keating GM
    Drugs; 2016 Jul; 76(10):1041-52. PubMed ID: 27324403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sugammadex: what do we know and what do we still need to know? A review of the recent (2013 to 2014) literature.
    Ledowski T
    Anaesth Intensive Care; 2015 Jan; 43(1):14-22. PubMed ID: 25579285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.